Japanese Journal of Clinical Oncology Advance Access originally published online on May 30, 2006
Japanese Journal of Clinical Oncology 2006 36(5):290-294; doi:10.1093/jjco/hyl030
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2006 Foundation for Promotion of Cancer Research
Monotherapy with Carbon Ion Radiation for Localized Prostate Cancer
1 Department of Urology, Graduate School of Medicine, Chiba University, 2 Research Center for Charged Particle Therapy, National Institute of Radiological Sciences, Chiba 3 Department of Surgical Pathology, Kanagawa Cancer Center, Yokohama, Japan
For reprints and all correspondence: Jun Shimazaki, Department of Urology, Graduate School of Medicine, Chiba University, Chuo-ku, Chiba-shi 260-8670, Japan. E-mail: shimajun{at}opal.famille.ne.jp
Received December 24, 2005; accepted February 13, 2006
Background: Radiation treatment for localized prostate cancer has become a prominent choice of monotherapy, and carbon ion beam is a powerful means for this purpose.
Methods: In total, 37 patients with localized prostate cancer were treated by monotherapy with carbon ion radiation and the outcome, more than 4 years later, was followed.
Results: PSA relapse-free survival was overall 85%, 5 years after radiation, and 96% in low-risk patients. Local control was mostly achieved, and no cancer-specific death was obtained. Except in cases of relapse, 1.0 ng/ml or less of PSA was shown in 78%, 3 years after radiation. Half of biopsy specimens out of 12 cases revealed non-viable or no cancer cells after a rather short time from treatment.
Conclusion: Monotherapy with carbon ion radiation may be an excellent treatment for localized prostate cancer with low risk.
Key Words: prostate cancer localized stage radiotherapy carbon ion radiation